Literature DB >> 1079706

The role of oxygen in retrolental fibroplasia.

A Patz.   

Abstract

The effects of oxygen in the immature or incompletely vascularized retina are conveniently divided into an initial vasoconstrictive and obliterative stage and a secondary vasoproliferative response that occurs after removal of the subject from an enriched oxygen environment. Vasoproliferation starts at the zone of perfused and nonperfused retina. The incompletely vascularized retina is uniquely responsive to these oxygen-induced changes. After vascularization is complete and the retinal vessels reach the ora, the susceptibility to hyperoxia disappears. The vessels in the temporal periphery of the retina have a peculiar susceptibility to the primary and secondary effects of hyperoxia on the immature retina. Ophthalmoscopic examination of the temporal periphery therefore should always be done carefully in the premature infant or in older individuals giving a history of prematurity. The indirect ophthalmoscope provides the most satisfactory instrument for examination. The incidence of retrolental fibroplasia has been greatly reduced following the incrimination of oxygen as its principal cause. Further studies are still required to determine precise blood oxygen levels that are safe for the premature retina and to discover other factors that may play a role in the pathogenesis or RLF.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1079706     DOI: 10.1007/bf00417111

Source DB:  PubMed          Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol        ISSN: 0065-6100


  11 in total

1.  DEVELOPMENT AND SENESCENCE OF THE HUMAN RETINAL VASCULATURE.

Authors:  D G COGAN
Journal:  Trans Ophthalmol Soc U K       Date:  1963

2.  ADJUSTMENT OF VENTILATION, INTRAPULMONARY GAS EXCHANGE, AND ACID-BASE BALANCE DURING THE FIRST DAY OF LIFE. INFANTS WITH EARLY RESPIRATORY DISTRESS.

Authors:  L S PRODHOM; H LEVISON; R B CHEERY; C A SMITH
Journal:  Pediatrics       Date:  1965-04       Impact factor: 7.124

3.  PRELIMINARY REPORT. THE PULMONARY HYPOPERFUSION SYNDROME.

Authors:  J CHU; J A CLEMENTS; E COTTON; M H KLAUS; A Y SWEET; M A THOMAS; W H TOOLEY
Journal:  Pediatrics       Date:  1965-05       Impact factor: 7.124

4.  Etiology of retrolental fibroplasia and preliminary report of cooperative study of retrolental fibroplasia.

Authors:  V E KINSEY; F M HEMPHILL
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1955 Jan-Feb

5.  Direct observation of the effect of oxygen on developing vessels: preliminary report.

Authors:  N ASHTON; C COOK
Journal:  Br J Ophthalmol       Date:  1954-07       Impact factor: 4.638

6.  Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations.

Authors:  A PATZ; L E HOECK; E DE LA CRUZ
Journal:  Am J Ophthalmol       Date:  1952-09       Impact factor: 5.258

7.  The role of oxygen in retrolental fibroplasia.

Authors:  A Patz
Journal:  Trans Am Ophthalmol Soc       Date:  1968

8.  Ophthalmoscopic monitoring of oxygen therapy in premature infants. Fluorescein angiography in acute retrolental fibroplasia.

Authors:  S J Cantolino; G E O'Grady; J A Herrera; C Israel; J Justice; J T Flynn
Journal:  Am J Ophthalmol       Date:  1971-08       Impact factor: 5.258

9.  The continuing role of the ophthalmologist in the premature nursery.

Authors:  A Patz
Journal:  Arch Ophthalmol       Date:  1971-02

Review 10.  The effect of oxygen on immature retinal vessels.

Authors:  A Patz
Journal:  Invest Ophthalmol       Date:  1965-12
View more
  3 in total

1.  Onset of retinopathy of prematurity as related to postnatal and postconceptional age.

Authors:  G E Quinn; L Johnson; S Abbasi
Journal:  Br J Ophthalmol       Date:  1992-05       Impact factor: 4.638

2.  Experimental studies on the pathogenesis of retinopathy of prematurity.

Authors:  M Prost
Journal:  Br J Ophthalmol       Date:  1988-05       Impact factor: 4.638

3.  Screening for retinopathy of prematurity in South of Iran.

Authors:  Mehrdad Afarid; Hamid Hosseini; Bagher Abtahi
Journal:  Middle East Afr J Ophthalmol       Date:  2012 Jul-Sep
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.